Effect of chemical structure and hydrophobicity on the pharmacokinetic properties of porphycenes in tumour-bearing mice

International Journal of Cancer

Volumn 72, Issue 2, 1997, Pages 329-336

  Segalla, Anna ^a   Fedeli, Francesco ^a   Reddi, Elena ^a   Jori, Giulio ^a   Cross, Alexander ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b Cytopharm Inc Menlo Park CA USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIOLEOYLPHOSPHATIDYLCHOLINE; LIPOSOME; MACROCYCLIC COMPOUND; PHOTOSENSITIZING AGENT; PORPHYRIN DERIVATIVE;

ABSORPTION SPECTROSCOPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG TARGETING; DRUG TISSUE LEVEL; FEMALE; FIBROSARCOMA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROPHOBICITY; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

ANIMALS; DRUG CARRIERS; FIBROSARCOMA; LIPOSOMES; MICE; MICE, INBRED BALB C; NEOPLASMS, EXPERIMENTAL; PORPHYRINS; TISSUE DISTRIBUTION;

EID: 0030803444     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970717)72:2<329::AID-IJC21>3.0.CO;2-9     Document Type: Article

References (23)

1. BERG, K., ANHOLT, H., MOAN, J., RONNESTAD, A. and RIMINGTON, C., Photobiological properties of haematoporphyrin diesters: evaluation of possible applications in photochemotherapy. J. Photochem. Photobiol. B Biol., 20, 37-45 (1993).
2. BERG, K., BOMMER, J.C., WINKELMAN, J.W. and MOAN, J., Cellular uptake and relative efficiency in cell inactivation by photoactivated su lphonated meso-tetraphenylporphines. Photochem. Photobiol., 52, 775-781 (1990).
3. BERG, K., and MOAN, J., Mitotic inhibition by phenylporphines and tetrasulfonated aluminium phthalocyanine in combination with light. Photochem. Photobiol., 56, 333-339 (1992).
4. BOYLE, R.W. and DOLPHIN, D., Structure and biodistributio relationships of photodynamic sensitizers. Photochem. Photobiol., 64, 469-485 (1996).
5. 6 in a mouse tumour model. Cancer Res., 52, 2890-2893 (1992).
6. GUARDIANO, M., BIOLO, R., JORI, G. and SCHAFFNER, K., Tetra-n-propylporphycene as a tumour localizer: pharmacokinetic and phototherapeutic studies in mice. Cancer Lett., 44, 1-6 (1989).
7. HSU, M.J. and JULIANO, R.L., Interaction of liposomes with the reticuloendothelial system. II. Non specific and receptor mediated uptake of liposomes by mouse peritoneal macrophages. Biochim. biophys. Acta, 720, 441-419 (1982).
8. JORI, G., Low-density lipoproteins-liposome delivery systems for tumour photosensitizers in vivo. In: B.W. Henderson and T.J. Dougherty (eds.), Photodynamic therapy, pp. 173-186, M. Dekker, New York (1992).
9. KESSEL, D. and KOHN, K.I., Transport and binding of mesoporphyrin IX by leukemia L1210 cells. Cancer Res., 40, 303-307 (1980).
10. KESSEL, D., THOMPSON, P., SAATIO, K. and NANTWI, K.D., Tumor localization and photosensitization by sulfonated derivatives of tetraphenylporphine. Photochem. Photobiol., 45, 787-790 (1987).
11. KIMEL, S., GOTTFRIED, V., DAVIDI, R. and AVERBUJ, C., In-vivo uptake and photodynamic activity of porphycenes. In: G. Jori, J. Moan and W.M. Star (eds.), Photodynamic therapy of cancer. Proc. SPIE 2078, pp. 205-211 (1994).
12. LEVY, J.G. and OBOCHI, M., New applications in photodynamic therapy. Photochem. Photobiol., 64, 737-739 (1996).
13. MARCUS, S.L., Clinical photodynamic therapy: the continuing evolution. In: B.W. Henderson and T.J. Dougherty (eds.), Photodynamic therapy, pp. 219-268, M. Dekker, New York (1992).
14. PENG, Q., MOAN, J., KONGSHAUG, M., EVENSEN, J.F., ANHOLT, H. and RIMINGTON, C., Sensitizer for photodynamic therapy of cancer: a comparison of the tissue distribution of Photofrin II and aluminum phthalocyanine tetrasulfonate in nude mice bearing a human malignant tumor. Int. J. Cancer, 8, 258-264 (1991).
15. REDDI, E., ZHOU, C., BIOLO, R., MENEGALDO, E. and JORI, G., Liposome-or LDL-administered Zn(II)-phthalocyanine as a photodynamic agent for tumours. I. Pharmacokinetic properties and phototherapeutic efficiency. Brit. J. Cancer, 61, 407-411 (1990).
16. REDMOND, R.W., VALDUGA, G., NONELL, S., BRASLAVSKY, S.E., SCHAFFNER, K., VOGEL, E., PRAMOD, K. and KÖCHNER, M., The photophysical properties of porphycenes incorporated in small unilamellar lipid vesicles. J. Photochem. Photobiol. B Biol., 3, 193-198 (1989).
17. RICHERT, C., A long-time-stable liposome formulation for porphyrinoid photosensitizers. J. Photochem. Photobiol. B Biol., 19, 67-73 (1993).
18. RICHERT, C., GAMARRA, F., HEIL, P., JOCHAM, D., VOGEL, E. and GOETZ, A.E., Ether-porphycenes: non-ionic polar side chains accelerate cell and serum kinetics and enhance cellular uptake of porphyrinoids. In: P. Spinelli, M. Dal Fante and R. Marchesini (eds.), Photodynamic therapy and medical lasers, pp. 702-708, Elsevier, Amsterdam (1992).
19. 3H-BPD-MA), a new potent photosensitizer in normal and tumour-bearing mice. J. Photochem. Photobiol. B Biol., 5, 231-244 (1990).
20. SANDBERG, S. and ROMSLO, I., Porphyrin-photosensitized photodynamic damage of isolated rat liver mitochondria. Biochim. biophys. Acta, 593, 187-195 (1980).
21. SONCIN, M., POLO, L., REDDI, E., JORI, G., KENNEY, M.E., CHENG, G. and RODGERS, M.A.J., Effect of axial ligation and delivery system on the tumour-localizing and photosensitizing properties of Ge(IV)-octabutoxy-phthalocyanines. Brit. J. Cancer, 71, 727-732 (1995).
22. VITOLS, S., Uptake of low-density lipoproteins by malignant cells. Possible therapeutic applications. Cancer Cells, 3, 488-495 (1991).
23. VOGEL, E., BALCI, M. PRAMOD, K., KOCH, P., LEX, J. and ERMER, O., 2,7,12,17-Tetrapropylporphycene: a counterpart of octaethylporphyrin in the porphycene series. Angew. Chem., 99, 909-911 (1987).